Swiss National Bank’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,329,024
| Closed | -$231M | – | 2601 |
|
|
2019
Q3 | $231M | Buy |
2,329,024
+40,128
| +2% | +$3.81M | 0.25% | 83 |
|
|
2019
Q2 | $212M | Sell |
2,288,896
-45,100
| -2% | -$4.28M | 0.23% | 87 |
|
|
2019
Q1 | $220M | Buy |
2,333,996
+47,400
| +2% | +$4.15M | 0.24% | 85 |
|
|
2018
Q4 | $147M | Sell |
2,286,596
-27,200
| -1% | -$2.01M | 0.19% | 109 |
|
|
2018
Q3 | $207M | Sell |
2,313,796
-173,100
| -7% | -$15.3M | 0.23% | 86 |
|
|
2018
Q2 | $198M | Sell |
2,486,896
-39,100
| -2% | -$3.25M | 0.23% | 92 |
|
|
2018
Q1 | $225M | Sell |
2,525,996
-359,700
| -12% | -$34.5M | 0.27% | 74 |
|
|
2017
Q4 | $301M | Buy |
2,885,696
+7,100
| +0.2% | +$801K | 0.33% | 62 |
|
|
2017
Q3 | $420M | Buy |
2,878,596
+36,000
| +1% | +$4.9M | 0.48% | 38 |
|
|
2017
Q2 | $369M | Buy |
2,842,596
+95,700
| +3% | +$11.7M | 0.44% | 37 |
|
|
2017
Q1 | $342M | Buy |
2,746,896
+588,000
| +27% | +$70.4M | 0.43% | 38 |
|
|
2016
Q4 | $250M | Buy |
2,158,896
+7,700
| +0.4% | +$858K | 0.39% | 45 |
|
|
2016
Q3 | $225M | Sell |
2,151,196
-39,800
| -2% | -$4.31M | 0.36% | 53 |
|
|
2016
Q2 | $216M | Buy |
2,190,996
+149,800
| +7% | +$15.5M | 0.35% | 57 |
|
|
2016
Q1 | $196M | Buy |
2,041,196
+605,200
| +42% | +$62.3M | 0.36% | 54 |
|
|
2015
Q4 | $172M | Buy |
1,435,996
+20,700
| +1% | +$2.39M | 0.42% | 42 |
|
|
2015
Q3 | $153M | Buy |
1,415,296
+123,500
| +10% | +$15.3M | 0.39% | 50 |
|
|
2015
Q2 | $150M | Buy |
1,291,796
+75,000
| +6% | +$8.57M | 0.39% | 53 |
|
|
2015
Q1 | $140M | Buy |
1,216,796
+473,400
| +64% | +$56.6M | 0.37% | 54 |
|
|
2014
Q4 | $83.2M | Sell |
743,396
-27,600
| -4% | -$2.91M | 0.31% | 73 |
|
|
2014
Q3 | $73.1M | Sell |
770,996
-20,400
| -3% | -$1.84M | 0.28% | 76 |
|
|
2014
Q2 | $68M | Sell |
791,396
-7,400
| -0.9% | -$563K | 0.25% | 88 |
|
|
2014
Q1 | $55.8M | Sell |
798,796
-77,600
| -9% | -$6.15M | 0.22% | 110 |
|
|
2013
Q4 | $74M | Sell |
876,396
-27,000
| -3% | -$2.14M | 0.29% | 78 |
|
|
2013
Q3 | $69.5M | Buy |
903,396
+12,000
| +1% | +$841K | 0.29% | 77 |
|
|
2013
Q2 | $52.1M | Buy |
+891,396
| New | +$53.6M | 0.23% | 109 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Swiss National Bank's CELG Position: Q4 2019 in Review
Swiss National Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,329,024 shares — an estimated $231M sold.
Swiss National Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $420M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Swiss National Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Swiss National Bank sold 2,329,024 Celgene Corp shares in Q4 2019, an estimated $231M.
- Swiss National Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Swiss National Bank's Celgene Corp position peaked at $420M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.